What is ACTO's business focus and history?

ACTO is a funded company based in Toronto, Canada, specializing in AI-powered platforms for the life sciences industry. Founded by Parth Khanna, Kumar Erramilli, and Kapil Kalra, ACTO offers products like LAICA RepAssist™ and CxZone to enhance field excellence. The company has secured $18 million in Series B funding led by Questa Capital. ACTO has received multiple awards, including certification as a Great Place to Work® in Canada for two consecutive years.

ACTO Corporate Details & Core Services

ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for life sciences that helps Sales, Marketing, and Medical teams improve customer engagement and brand performance by turning field professionals into 'Masters of the Message' who engage healthcare providers and their support teams with authority and impact.

ACTO Contact Information & Official Links

Website https://acto.com
Social    
Email id sales@actoapp.com
Phone number +1 844 277 2286
Head office address Toronto, Ontario, Canada
Tags AI-powered platform Life sciences Sales enablement Medical affairs Omnichannel learning

What are ACTO's Key Business Metrics & Stats?

No of employees 200
Founded year
Type private
Industry Healthcare Services, Software
Location Toronto, Ontario, Canada
ACTO Firmographic Snapshot 2026 Founded Year 200 Global Employees Canada Headquarters HealthcareServices,Software Industry Private Type Verified by DexterAgent.ai

How much funding has ACTO raised to date?

Name Description
Funding Amount USD 18 Million
Stage Series B
Latest Valuation (USD)
Lead Investor Questa Capital
Investors Questa Capital, Resolve Growth Partners, Salesforce Ventures, Panache Ventures, MaRS Investment Accelerator Fund

What are ACTO's Core Products?

Name Description
LAICA RepAssistâ„¢ A mobile-friendly, voice-enabled conversational knowledge assistant that provides field professionals with instant access to approved clinical and product information during healthcare provider interactions.
CxZone An AI-simulated roleplay solution built exclusively for pharma field professionals to build clinical fluency, confidence, and adaptability for real-world healthcare provider conversations.

What are the latest developments at ACTO?

Date Type Description
October, 2024 Product Launch ACTO launches LAICA RepAssistâ„¢, the first genAI knowledge assistant built specifically for the life sciences industry.
July, 2022 Funding ACTO secures $18M financing to accelerate growth and strengthen position as #1 learning platform in life sciences.

What industry awards and recognitions has ACTO received?

Date Type Description
February, 2022 Certification Certified as a Great Place to Work® in Canada for the second consecutive year.
December, 2019 Award Gold in the Cloud Platform category from the Stevie International Business Awards.
Name Description
Legal Name ACTO Technologies, Inc.
Cin number
GST number
Registration number

Who is in ACTO's executive leadership team?

Name Designation
CEO Parth Khanna
Chief Finance Officer Jenny Yeung
Chief Technology Officer Kumar Erramilli
Chief Revenue Officer Kapil Kalra
Chief Marketing Officer Alison Muller
Chief Sales Officer John Schultz

Where are ACTO's primary office locations?

City Country
Toronto Canada
Philadelphia USA
New York USA
Bangalore India
São Paulo Brazil

What are the current business signals and market intelligence for ACTO?

Type of customer Pharmaceutical companies, Medical device companies, Biopharmaceutical companies
Key customer domain

What are ACTO's risk management and compliance ratings?

GDPR RIsk No
Privacy Risk No
Company Ratings
Glassdoor Rating

What are ACTO's business model and service classifications?

Saas Yes
Offline Stores No
Service Yes
Ecommerce No
Exporter No
Mobile App Yes
Retail No
B2B Yes
B2C No
Manufacturing No
Wholesale No
Importer No
Get Company Intelligence in API
(Price is 0.1 USD/Record - pay as you go)

 

Get Company Intelligence in API
(Price is 0.1 USD/Record - pay as you go)